297 posters,  10 topics,  260 authors,  189 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

131
A clinical evaluation of UrgoClean Ag in the management of wounds with local infection

Primary tabs

Rate

No votes yet

Statistics

386 reads

CLINICAL EVALUATION OF URGOCLEAN AG IN THE MANAGEMENT
OF WOUNDS WITH LOCAL INFECTIONS

 

INTRODUCTION
Wound infections delay healing, cause pain and
antibiotic resistance is making them increasingly
difficult to treat 1.
Critical colonisation of a wound occurs when
the level of bacteria is high but not of a level to
cause infection. Local infection in wounds can
present with an increase in exudate and slough
that does not respond to treatment or returns
quickly following debridement. This facilitates
an ideal environment for bacterial growth and
biofilm formation. UrgoClean Ag comprises of
two technologies that reduce local infection. It
consists of poly absorbent fibres which trap and
bind wound debris away from the wound bed
and the TLC-Ag matrix which ensures sustained
release of silver to the wound bed and pain free
removal at dressing change.
METHOD
Following assessment by a Tissue Viability
Nurse Specialist patients with leg ulcers and
pressure ulcers that were presenting with local
infection/critical colonisation requiring a topical
antimicrobial were commenced on a treatment
of UrgoClean Ag once consent was gained. All
clinicians who would be applying the dressing
were offered guidance on the use of the dressing
in accordance with the manufacturer’s indications
and all patients were treated in accordance with
the instructions for use.
All wounds were measured and photographed
weekly during the evaluation and frequency of
redressing depended on the clinical need.
The following outcomes were recorded:
• Clinical signs and symptoms of critical colonisation
• Current level of pain
• Exudate level of the wound
• Ease of product application
• Conformability to the wound bed
• Patient comfort
• Ease of removal
RESULTS
Clinical signs and symptoms of critical
colonisation improved and pain also reduced with
staff and patients reporting that the dressing was
comfortable and conformable and patient comfort
on dressing removal was also excellent.
UrgoClean Ag was very easy to apply and the
soft adherent TLC layer helped to keep the
dressing in place.
CONCLUSION
Six patients were involved in this evaluation and
UrgoClean Ag performed well during this process
with clinical signs of critical colonisation reduced
and nobody requiring follow-on antibiotic therapy.
Staff and patients all reported positive experiences
with the outcome of using UrgoClean Ag.

Enter Poster ID (e.gGoNextPreviousCurrent